Related Experiment Videos
Relationship between platelet cyclooxygenase pathway and plasma malondialdehyde-like material
Lipids
|May 1, 1985
Summary
Aspirin significantly reduced platelet malondialdehyde (MDA) formation and plasma MDA-like material (MDA-LM) within 24 hours. These markers returned to baseline within 7 days, suggesting aspirin
Area of Science:
- Biochemistry
- Pharmacology
- Hematology
Background:
- Thrombin stimulates platelet malondialdehyde (MDA) formation.
- Plasma malondialdehyde-like material (MDA-LM) is a marker influenced by platelet activity.
Purpose of the Study:
- To evaluate the effect of aspirin on platelet MDA and plasma MDA-LM.
- To assess the duration of aspirin's impact on these markers.
- To explore the utility of plasma MDA-LM in assessing in vivo platelet cyclooxygenase activation.
Main Methods:
- 12 healthy subjects ingested 1 g of aspirin.
- Platelet MDA and plasma MDA-LM were measured at baseline, 1 day, and 7 days post-ingestion.
Main Results:
- Aspirin administration almost abolished platelet MDA formation 24 hours after ingestion.
- Plasma MDA-LM decreased by 23% at 24 hours post-aspirin.
- Both platelet MDA and plasma MDA-LM returned to baseline levels by 7 days.
Conclusions:
- Platelet cyclooxygenase pathway partially influences plasma MDA-LM.
- Plasma MDA-LM evaluation before and after aspirin may indicate in vivo platelet cyclooxygenase activation.